55 million Indians are pushed below the poverty line as a result of heavy medical bills every year. One reason for this is the abysmally low pace of health insurance penetration in the country. But that’s not all.
Piramal Enterprises said on Wednesday that it will raise up to Rs 2,750 crore by issuing bonds on private placement basis.
Equity benchmark indices scaled fresh new highs on Wednesday and ended half a per cent higher due to heavy buying in auto, metal and pharma stocks. The bull run continued amid positive underlying sentiment and optimism surrounding the signing of US-China trade deal’s first phase.
As many as 20 Indian generic drug manufacturing firms have been hit with a US anti-trust lawsuit.
Recent warnings and crackdowns from US FDA and its Indian counterpart CDSCO have again brought the grave danger that adulterated and substandard products that pharma manufacturers are putting out in a largely unaware and uneducated market. HEAD SHOT USFDA recently reproached…